• Latest Posts
Interview 22 Jun 2018

Swedish Biotech’s Liquid Biopsy Could Improve Accuracy of Cancer Diagnoses

Radiotherapy-Enhancing Cancer Nanomedicine Secures Good Phase II/III Results

Next-Generation CAR-T Company Raises €130M on NASDAQ IPO

Gene Editing Could Cut the Cost of One of the Most Expensive Animal Diseases in the World

Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes

Interview 20 Jun 2018

“Have the guts to follow your instincts”: Top CEO Talks About His Time in Biotech

A Chip Could Help Us Identify Wheeze-Causing Types of Viruses

Biomaterial to Regenerate Teeth Approved in Europe

More News! 18 Jun 2018

Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage

London Pharma Company Rakes in Positive Results for Two HIV Phase III Trials